Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
05/2001
05/09/2001CN1294589A Process for production of purine derivatives and intermediates therefor
05/08/2001US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents
05/08/2001US6228860 Substituted 1,3-oxathiolanes with antiviral properties
05/08/2001US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/02/2001EP1095031A1 Antiviral macrocyclic compounds
05/02/2001EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
05/01/2001CA2268703C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity
04/2001
04/26/2001WO2001029039A1 Synthesis and methods of use of 9-substituted guanine derivatives
04/26/2001WO2001028545A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
04/26/2001CA2384789A1 Synthesis and methods of use of 9-substituted guanine derivatives
04/26/2001CA2384573A1 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
04/25/2001CN1292789A 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221874 Method of treating bone loss by stimulation of calcitonin
04/24/2001US6221873 Cyclin dependent kinase inhibitor
04/19/2001WO2001027131A1 Purine derivatives
04/19/2001WO2001027130A1 Purine derivatives
04/18/2001EP1092718A1 2-(2-Alkoxy-5-heterocyclylsulphonylphenyl)purin-6-ones as phosphodiesterase inhibitors
04/18/2001EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
04/18/2001CN1291983A 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
04/18/2001CN1064683C Process for preparing purine derivatives
04/17/2001US6218568 Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
04/17/2001US6218387 Vitronectin receptor anatagonists, their preparation and their use
04/12/2001WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2
04/11/2001EP1090019A1 Adenosine derivatives
04/11/2001CN1064361C Xanthine compounds having terminally aminated alkynol side chains
04/10/2001US6215017 1-aralkyloxy-3-acyloxy-2-(acyloxy)methoxypropane derivative; chemical intermediates for viricide ganciclovir
04/10/2001US6215004 Cyclization of mercaptoacetic acid with acetal in solvent; sulfiding
04/10/2001US6214993 Process for preparing guanine under superatmospheric pressure
04/10/2001US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
04/10/2001US6214870 Antiarthritic agents; anticancer agents
04/10/2001US6214840 Annulated azole derivatives useful as microbicidal agents
04/05/2001WO2001023399A1 Compounds for the treatment of ischemia
04/05/2001WO2001023389A2 Certain alkylene diamine-substituted heterocycles
04/05/2001WO2001023378A1 Pharmaceutically active sulfonamide derivatives
04/05/2001WO2001002400A8 Fused imidazole compounds and remedies for diabetes mellitus
04/05/2001CA2386079A1 Compounds for the treatment of ischemia
04/04/2001EP1088821A1 Pharmaceutically active sulfonamide derivatives
04/04/2001EP1087962A1 Preparation of heteroaryl compounds
04/04/2001EP0861841B1 Process for producing 2-amino-6-iodopurine
04/03/2001US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity
04/03/2001US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates
04/03/2001US6210687 Fat emulsion containing xanthine derivative
04/03/2001CA2188147C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
03/2001
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/28/2001CN1289334A Benzothiadiazoles and derivatives
03/27/2001US6207693 Benzamide derivatives having a vasopressin antagonistic activity
03/21/2001EP1085020A1 Synthesis of modified diaminopurines and their incorporation into oligomers
03/21/2001EP1084123A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
03/21/2001EP0862570B1 Process for the preparation of 9- (2-hydroxyethoxy)methyl]guanine
03/21/2001CN1288456A Substances capable of inducing appotosis
03/20/2001US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors
03/20/2001CA2206287C Aryl thioxanthines
03/15/2001WO2001018003A1 Carbocyclic nucleosides and process for obtaining such
03/15/2001WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives
03/15/2001WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents
03/15/2001WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components
03/15/2001CA2383798A1 Pulmonary delivery for bioconjugation
03/15/2001CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents
03/14/2001EP0702682B1 Process for the preparation of amino acid esters of nucleoside analogues
03/13/2001US6200980 Method of treating a patient having precancerous lesions with phenyl purinone derivatives
03/08/2001WO2001016134A1 Selective antagonists of a2b adenosine receptors
03/08/2001WO1999064047A8 Novel antiviral compounds
03/07/2001EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/06/2001US6197777 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
03/06/2001CA2223081C Heterocyclic ring-fused pyrimidine derivatives
03/06/2001CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines
03/01/2001WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
03/01/2001WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
02/2001
02/28/2001EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins
02/28/2001CN1285833A Purine derivatives and medicine containing the same as the active ingredient
02/27/2001CA2124206C Indole derivatives
02/22/2001WO2001011967A1 Novel hypoxanthine and thiohypoxanthine compounds
02/22/2001CA2379356A1 Novel hypoxanthine and thiohypoxanthine compounds
02/20/2001US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant
02/20/2001US6191266 Sugar modified nucleosides
02/20/2001US6191161 Prolylendopeptidase inhibitors
02/20/2001CA2192289C Substituted heterocyclic derivatives
02/15/2001WO2001010380A2 Benzanilides as potassium channel openers
02/15/2001CA2378241A1 Benzanilides as potassium channel openers
02/14/2001CN1284077A Purine derivatives having phosphodiesterase IV inhibition activity
02/14/2001CN1284076A 2-aryl-8-oxodihydropurine derivatives, process for producting same, medicinal conty. same, and intermediates thereof
02/13/2001US6187925 Intermediates and process for the synthesis of azasteroids
02/13/2001US6187922 Process for the preparation of purine derivatives
02/13/2001US6187921 2-amino-6-chloropurine having double cone-like crystal form constructed by combining two pyramids with each other at their bottoms and having specified average particle diameter
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 120